WELLBUTRIN

Product NDC: 0187-0730
11-digit product format: 001870730
Labeler code: 0187
Product ID: 0187-0730_22308f71-fc56-430d-b559-bed47e17a46c
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: bupropion hydrochloride
Dosage form: TABLET, EXTENDED RELEASE
Route: ORAL
Labeler: Bausch Health US LLC
Application: NDA021515
Marketing category: NDA
Marketing start: 2003-08-29
Substance: BUPROPION HYDROCHLORIDE
Active strength: 150 mg/1
Pharmacologic classes: Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]
NDC exclude flag: No
Listing certified through: 2027-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N021515-001	WELLBUTRIN XL	BUPROPION HYDROCHLORIDE	150MG	TABLET, EXTENDED RELEASE / ORAL	AB3	RLD	2003-08-28
N021515-002	WELLBUTRIN XL	BUPROPION HYDROCHLORIDE	300MG	TABLET, EXTENDED RELEASE / ORAL	AB3	RLD, RS	2003-08-28

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-product	TE code
N021515-001	AB3
N021515-002	AB3

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 82 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N021515-001	WELLBUTRIN XL	150MG	TABLET, EXTENDED RELEASE / ORAL	AB3	RLD	2003-08-28	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021515-002	WELLBUTRIN XL	300MG	TABLET, EXTENDED RELEASE / ORAL	AB3	RLD, RS	2003-08-28	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021515-001	WELLBUTRIN XL	150MG	TABLET, EXTENDED RELEASE / ORAL	AB3	RLD	2003-08-28	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021515-002	WELLBUTRIN XL	300MG	TABLET, EXTENDED RELEASE / ORAL	AB3	RLD, RS	2003-08-28	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N021515-001	WELLBUTRIN XL	150MG	TABLET, EXTENDED RELEASE / ORAL	AB3	RLD	2003-08-28	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021515-002	WELLBUTRIN XL	300MG	TABLET, EXTENDED RELEASE / ORAL	AB3	RLD, RS	2003-08-28	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021515-001	WELLBUTRIN XL	150MG	TABLET, EXTENDED RELEASE / ORAL	AB3	RLD	2003-08-28	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021515-002	WELLBUTRIN XL	300MG	TABLET, EXTENDED RELEASE / ORAL	AB3	RLD, RS	2003-08-28	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021515-001	WELLBUTRIN XL	150MG	TABLET, EXTENDED RELEASE / ORAL	AB3	RLD	2003-08-28	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021515-002	WELLBUTRIN XL	300MG	TABLET, EXTENDED RELEASE / ORAL	AB3	RLD, RS	2003-08-28	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021515-001	WELLBUTRIN XL	150MG	TABLET, EXTENDED RELEASE / ORAL	AB3	RLD	2003-08-28	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021515-002	WELLBUTRIN XL	300MG	TABLET, EXTENDED RELEASE / ORAL	AB3	RLD, RS	2003-08-28	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021515-001	WELLBUTRIN XL	150MG	TABLET, EXTENDED RELEASE / ORAL	AB3	RLD	2003-08-28	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021515-002	WELLBUTRIN XL	300MG	TABLET, EXTENDED RELEASE / ORAL	AB3	RLD, RS	2003-08-28	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021515-001	WELLBUTRIN XL	150MG	TABLET, EXTENDED RELEASE / ORAL	AB3	RLD	2003-08-28	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021515-002	WELLBUTRIN XL	300MG	TABLET, EXTENDED RELEASE / ORAL	AB3	RLD, RS	2003-08-28	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021515-001	WELLBUTRIN XL	150MG	TABLET, EXTENDED RELEASE / ORAL	AB3	RLD	2003-08-28	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021515-002	WELLBUTRIN XL	300MG	TABLET, EXTENDED RELEASE / ORAL	AB3	RLD, RS	2003-08-28	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N021515-001	WELLBUTRIN XL	150MG	TABLET, EXTENDED RELEASE / ORAL	AB3	RLD	2003-08-28	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N021515-002	WELLBUTRIN XL	300MG	TABLET, EXTENDED RELEASE / ORAL	AB3	RLD, RS	2003-08-28	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N021515-001	WELLBUTRIN XL	150MG	TABLET, EXTENDED RELEASE / ORAL	AB3	RLD	2003-08-28	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N021515-002	WELLBUTRIN XL	300MG	TABLET, EXTENDED RELEASE / ORAL	AB3	RLD, RS	2003-08-28	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N021515-001	WELLBUTRIN XL	150MG	TABLET, EXTENDED RELEASE / ORAL	AB3	RLD	2003-08-28	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N021515-002	WELLBUTRIN XL	300MG	TABLET, EXTENDED RELEASE / ORAL	AB3	RLD, RS	2003-08-28	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N021515-001	WELLBUTRIN XL	150MG	TABLET, EXTENDED RELEASE / ORAL	AB3	RLD	2003-08-28	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N021515-002	WELLBUTRIN XL	300MG	TABLET, EXTENDED RELEASE / ORAL	AB3	RLD, RS	2003-08-28	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N021515-001	WELLBUTRIN XL	150MG	TABLET, EXTENDED RELEASE / ORAL	AB3	RLD	2003-08-28	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	N021515-002	WELLBUTRIN XL	300MG	TABLET, EXTENDED RELEASE / ORAL	AB3	RLD, RS	2003-08-28	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N021515-001	WELLBUTRIN XL	150MG	TABLET, EXTENDED RELEASE / ORAL	AB3	RLD	2003-08-28	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N021515-002	WELLBUTRIN XL	300MG	TABLET, EXTENDED RELEASE / ORAL	AB3	RLD, RS	2003-08-28	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N021515-001	WELLBUTRIN XL	150MG	TABLET, EXTENDED RELEASE / ORAL	AB3	RLD	2003-08-28	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	N021515-002	WELLBUTRIN XL	300MG	TABLET, EXTENDED RELEASE / ORAL	AB3	RLD, RS	2003-08-28	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N021515-001	WELLBUTRIN XL	150MG	TABLET, EXTENDED RELEASE / ORAL	AB3	RLD	2003-08-28	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	N021515-002	WELLBUTRIN XL	300MG	TABLET, EXTENDED RELEASE / ORAL	AB3	RLD, RS	2003-08-28	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N021515-001	WELLBUTRIN XL	150MG	TABLET, EXTENDED RELEASE / ORAL	AB3	RLD	2003-08-28	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021515-002	WELLBUTRIN XL	300MG	TABLET, EXTENDED RELEASE / ORAL	AB3	RLD, RS	2003-08-28	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N021515-001	WELLBUTRIN XL	150MG	TABLET, EXTENDED RELEASE / ORAL	AB3	RLD	2003-08-28	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	N021515-002	WELLBUTRIN XL	300MG	TABLET, EXTENDED RELEASE / ORAL	AB3	RLD, RS	2003-08-28	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N021515-001	WELLBUTRIN XL	150MG	TABLET, EXTENDED RELEASE / ORAL	AB3	RLD	2003-08-28	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	N021515-002	WELLBUTRIN XL	300MG	TABLET, EXTENDED RELEASE / ORAL	AB3	RLD, RS	2003-08-28	`782e0a99824c…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 3 · 82 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N021515-001	AB3	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N021515-002	AB3	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021515-001	AB3	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021515-002	AB3	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N021515-001	AB3	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N021515-002	AB3	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021515-001	AB3	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021515-002	AB3	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021515-001	AB3	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021515-002	AB3	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021515-001	AB3	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021515-002	AB3	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021515-001	AB3	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021515-002	AB3	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021515-001	AB3	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021515-002	AB3	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021515-001	AB3	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021515-002	AB3	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N021515-001	AB3	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N021515-002	AB3	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N021515-001	AB3	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N021515-002	AB3	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N021515-001	AB3	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N021515-002	AB3	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N021515-001	AB3	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N021515-002	AB3	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N021515-001	AB3	1	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	N021515-002	AB3	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N021515-001	AB3	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N021515-002	AB3	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N021515-001	AB3	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	N021515-002	AB3	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N021515-001	AB3	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	N021515-002	AB3	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N021515-001	AB3	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021515-002	AB3	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N021515-001	AB3	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	N021515-002	AB3	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N021515-001	AB3	1	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	N021515-002	AB3	1	`782e0a99824c…`

Additional Listing Data#

Finished product: Yes
Brand name base: WELLBUTRIN
Brand name suffix: XL
Listing expiration: 2027-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
BUPROPION HYDROCHLORIDE	150 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
ZG7E5POY8O	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 4 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
993541	Internal RxNorm lookup
993545	Internal RxNorm lookup
993557	Internal RxNorm lookup
993564	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
a435da9d-f6e8-4ddc-897d-8cd2bf777b21	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
4eceb285-f3c7-4092-a21a-4c9f3169f20c	Product name	5	20260220
548ba7fd-fd0c-4a21-b2b0-d01bf93143b8	Product name	3	20240209
43a1ed49-eae2-4840-8075-cb4b33478540	Product name	1	20230425
b8ee525f-67fb-39fb-91da-7e47ac54581d	Product name	5	20200611
98e65af1-f5d0-75d5-c930-f8a4ce4c3284	Product name	9	20190211
e4d463bc-c674-43cb-be06-82786f310d01	Product name	1	20150326
0916dcfb-331f-89b1-8eac-6f7dc76d82da	Product name	1	20140508
d7fc3d53-5a6c-de82-2808-1780f175f17e	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
0187-0730-07	WELLBUTRINXL	7 in 1 BOTTLE	TABLET, EXTENDED RELEASE	7	27
0187-0730-30	WELLBUTRINXL	30 in 1 BOTTLE	TABLET, EXTENDED RELEASE	30	27
0187-0730-90	WELLBUTRINXL	90 in 1 BOTTLE	TABLET, EXTENDED RELEASE	90	27

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0187-0730-07	EA - Each	0187-0730	828f7059-f55e-44ce-91e0-02fad9d88f90	1	2021-09-07
0187-0730-30	EA - Each	0187-0730	70e78a9b-0dba-4d0c-bee9-92f5c00c7481	1	2013-02-13
0187-0730-90	EA - Each	0187-0730	45104a29-39ea-4e61-9c29-79af08ef30ef	1	2013-02-13

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
BUPROPION HYDROCHLORIDE	ACTIVE INGREDIENT	ZG7E5POY8O	WELLBUTRIN XL (BUPROPION HYDROCHLORIDE) TABLET, EXTENDED RELEASE [VALEANT PHARMACEUTICALS NORTH AMERICA LLC]	6
BUPROPION	ACTIVE MOIETY	01ZG3TPX31	WELLBUTRIN XL (BUPROPION HYDROCHLORIDE) TABLET, EXTENDED RELEASE [VALEANT PHARMACEUTICALS NORTH AMERICA LLC]	6
ETHYLCELLULOSES	INACTIVE INGREDIENT	7Z8S9VYZ4B	WELLBUTRIN XL (BUPROPION HYDROCHLORIDE) TABLET, EXTENDED RELEASE [VALEANT PHARMACEUTICALS NORTH AMERICA LLC]	6
GLYCERYL DIBEHENATE	INACTIVE INGREDIENT	R8WTH25YS2	WELLBUTRIN XL (BUPROPION HYDROCHLORIDE) TABLET, EXTENDED RELEASE [VALEANT PHARMACEUTICALS NORTH AMERICA LLC]	6
METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A	INACTIVE INGREDIENT	NX76LV5T8J	WELLBUTRIN XL (BUPROPION HYDROCHLORIDE) TABLET, EXTENDED RELEASE [VALEANT PHARMACEUTICALS NORTH AMERICA LLC]	6
POLYETHYLENE GLYCOLS	INACTIVE INGREDIENT	3WJQ0SDW1A	WELLBUTRIN XL (BUPROPION HYDROCHLORIDE) TABLET, EXTENDED RELEASE [VALEANT PHARMACEUTICALS NORTH AMERICA LLC]	6
POLYVINYL ALCOHOL	INACTIVE INGREDIENT	532B59J990	WELLBUTRIN XL (BUPROPION HYDROCHLORIDE) TABLET, EXTENDED RELEASE [VALEANT PHARMACEUTICALS NORTH AMERICA LLC]	6
POVIDONES	INACTIVE INGREDIENT	FZ989GH94E	WELLBUTRIN XL (BUPROPION HYDROCHLORIDE) TABLET, EXTENDED RELEASE [VALEANT PHARMACEUTICALS NORTH AMERICA LLC]	6
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	WELLBUTRIN XL (BUPROPION HYDROCHLORIDE) TABLET, EXTENDED RELEASE [VALEANT PHARMACEUTICALS NORTH AMERICA LLC]	6
TRIETHYL CITRATE	INACTIVE INGREDIENT	8Z96QXD6UM	WELLBUTRIN XL (BUPROPION HYDROCHLORIDE) TABLET, EXTENDED RELEASE [VALEANT PHARMACEUTICALS NORTH AMERICA LLC]	6

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
0187-0730	WELLBUTRIN XL (BUPROPION HYDROCHLORIDE) TABLET, EXTENDED RELEASE [BAUSCH HEALTH US LLC]	23	Current NDC, Legacy NDC, 3 package rows	20240810_a435da9d-f6e8-4ddc-897d-8cd2bf777b21.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
WELLBUTRIN XL	BUPROPION HYDROCHLORIDE	Bausch Health US LLC	a435da9d-f6e8-4ddc-897d-8cd2bf777b21	2026-02-10	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (NDA): 021515 application number: NDA021515 ndc (product): 0187-0730

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
ZG7E5POY8O	BUPROPION HYDROCHLORIDE	31677-93-7	BUPROPION HYDROCHLORIDE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
993541	buPROPion HCl 150 MG 24HR Extended Release Oral Tablet	PSN	a435da9d-f6e8-4ddc-897d-8cd2bf777b21	27
993557	buPROPion HCl 300 MG 24HR Extended Release Oral Tablet	PSN	a435da9d-f6e8-4ddc-897d-8cd2bf777b21	27
993545	Wellbutrin XL 150 MG 24HR Extended Release Oral Tablet	PSN	a435da9d-f6e8-4ddc-897d-8cd2bf777b21	27
993564	Wellbutrin XL 300 MG 24HR Extended Release Oral Tablet	PSN	a435da9d-f6e8-4ddc-897d-8cd2bf777b21	27
993545	24 HR bupropion hydrochloride 150 MG Extended Release Oral Tablet [Wellbutrin]	SBD	a435da9d-f6e8-4ddc-897d-8cd2bf777b21	27
993564	24 HR bupropion hydrochloride 300 MG Extended Release Oral Tablet [Wellbutrin]	SBD	a435da9d-f6e8-4ddc-897d-8cd2bf777b21	27
993541	24 HR bupropion hydrochloride 150 MG Extended Release Oral Tablet	SCD	a435da9d-f6e8-4ddc-897d-8cd2bf777b21	27
993557	24 HR bupropion hydrochloride 300 MG Extended Release Oral Tablet	SCD	a435da9d-f6e8-4ddc-897d-8cd2bf777b21	27
993545	24 HR Wellbutrin 150 MG Extended Release Oral Tablet	SY	a435da9d-f6e8-4ddc-897d-8cd2bf777b21	27
993564	24 HR Wellbutrin 300 MG Extended Release Oral Tablet	SY	a435da9d-f6e8-4ddc-897d-8cd2bf777b21	27
993541	bupropion HCl XL 150 MG 24 HR Extended Release Oral Tablet	SY	a435da9d-f6e8-4ddc-897d-8cd2bf777b21	27
993557	bupropion HCl XL 300 MG 24 HR Extended Release Oral Tablet	SY	a435da9d-f6e8-4ddc-897d-8cd2bf777b21	27
993545	Wellbutrin XL 150 MG 24 HR Extended Release Oral Tablet	SY	a435da9d-f6e8-4ddc-897d-8cd2bf777b21	27
993564	Wellbutrin XL 300 MG 24 HR Extended Release Oral Tablet	SY	a435da9d-f6e8-4ddc-897d-8cd2bf777b21	27

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
0187-0730-07	00187073007	7 TABLET, EXTENDED RELEASE in 1 BOTTLE (0187-0730-07)	2003-08-29	0000-00-00	No	No	Current
0187-0730-30	00187073030	30 TABLET, EXTENDED RELEASE in 1 BOTTLE (0187-0730-30)	2003-08-29	0000-00-00	No	No	Current
0187-0730-90	00187073090	90 TABLET, EXTENDED RELEASE in 1 BOTTLE (0187-0730-90)	2003-08-29	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
WELLBUTRIN XL	Bausch Health US LLC \| Bausch Health Companies Inc.	2026-02-10	HUMAN PRESCRIPTION DRUG LABEL	27